| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 31,280,000 | 44,904,000 | 74,544,000 | 70,182,000 | | Cost of Revenue | 22,529,000 | 33,451,000 | 52,934,000 | 54,613,000 | | | Gross Profit | 8,751,000 | 11,453,000 | 21,610,000 | 15,569,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,939,000 | 4,617,000 | 6,143,000 | 6,425,000 | | Non Recurring | 3,000 | 34,457,000 | 57,000 | 19,000 | | Others | 2,334,000 | 1,950,000 | 2,675,000 | 2,074,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,475,000 | (29,571,000) | 12,735,000 | 7,051,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (131,000) | (535,000) | 157,000 | (200,000) | | Earnings Before Interest And Taxes | 2,344,000 | (30,125,000) | 9,706,000 | 10,005,000 | | Interest Expense | 310,000 | 279,000 | 239,000 | 210,000 | | Income Before Tax | 2,034,000 | (30,404,000) | 9,467,000 | 9,795,000 | | Income Tax Expense | 1,178,000 | 1,360,000 | 4,279,000 | 4,356,000 | | Minority Interest |
-
| (19,000) | (15,000) | (17,000) | | | | Net Income From Continuing Ops | 856,000 | (31,764,000) | 5,188,000 | 5,439,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 856,000 | (31,764,000) | 5,188,000 | 5,439,000 | | Preferred Stock And Other Adjustments | (16,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $840,000 | ($31,764,000) | $5,188,000 | $5,439,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
